Today

How the Rising Cost of College Is Changing Families’ Calculus

Rounding out our week looking at the finances of parenting, we’re looking at one of the biggest costs families can face: college. About 18 million students enrolled in post-secondary education this spring. That’s up from last year. And so is the price of tuition. Sandra Kilhof sp ... Show More

13m 28s

Yesterday

What’s News in Markets: Home Depot Rallies, Target Misses, Meta Pauses

How did Home Depot bounce back in spite of a mixed bag of a quarterly report? And what caused a leadership shakeup at Target? Plus, why is Meta pausing hiring in its AI division? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Si ... Show More

5m 43s

Aug 22

DOJ Releases Ghislaine Maxwell Interview Transcript

P.M. Edition for Aug. 22. The Justice Department has released interview transcripts of Jeffrey Epstein associate Ghislaine Maxwell. And U.S. stocks surged after Fed Chair Jerome Powell signaled rate cuts are coming. WSJ’s chief economic correspondent Nick Timiraos discusses if Po ... Show More

14m 17s

Apr 2025

What’s News in Markets: Capital One Gains, Consumer Conglomerate Woes, Alphabet Earnings Shine

Why did Capital One’s merger news please investors? And how are tariffs worrying consumer conglomerates like Procter & Gamble? Plus, how Google parent Alphabet’s financials are holding up–for now. Host Francesca Fontana discusses the biggest stock moves of the week and the news t ... Show More

5m 33s

Jul 19

What’s News in Markets: Bank Earnings, Nvidia Gains, MP Materials Deal

Why were bank stocks down if bank earnings were strong? And how is Nvidia back in business in China? Plus, which company did MP Materials strike a deal with this week? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for t ... Show More

5m 40s

May 21

Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

Blockbuster drugs. Rising profits. Strong sales. And yet, Novo Nordisk, the Danish company behind the GLP-1 drugs Ozempic and Wegovy, made a surprising move last week: It pushed out its CEO. WSJ's Peter Loftus charts the rise of Ozempic and the fall of CEO Lars Jorgensen. Jessica ... Show More

20m 12s

Jul 2024

Dow Falls More Than 500 Points

Plus: Shares of Eli Lilly and Novo Nordisk decline as competition in the anti-obesity drug market ramps up. After the bell, Netflix reported stronger revenue, but said subscriber growth in the current quarter will be weaker than a year ago. J.R. Whalen reports. Sign up for the WS ... Show More

2m 37s

Jun 21

What’s News in Markets: U.S. Steel Deal, SunRun Sinks, 23andMe Slides

How did U.S. Steel shares react to White House deal approval? And why did solar stocks slide after Senate revisions to the big budget bill? Plus, what’s the latest twist in the 23andMe sale drama? Host Francesca Fontana discusses the biggest stock moves of the week and the news t ... Show More

5m 21s

Aug 2024

What’s News in Markets: Meta’s Ads, Moderna’s Health, Intel’s Struggles

How is Meta’s advertising business doing? And is Moderna in trouble after the end of the pandemic? Plus, why did Intel’s stock short-circuit? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Learn more about your ad choices. Visit ... Show More

5m 16s

Jan 2025

U.S. Indexes Trim Gains After Strong Week

Plus: American Express shares fell after its outlook for the year disappointed investors. Verizon stock rose after beating Wall Street expectations. And Novo Nordisk surged after positive results from a clinical trial of an experimental weight loss drug. Danny Lewis reports. Sign ... Show More

2m 32s

What’s News in Markets: Lilly Surges, Un...